Sign Up to like & get
recommendations!
0
Published in 2021 at "PLoS Pathogens"
DOI: 10.1371/journal.ppat.1009749
Abstract: The main avenue for the development of an HIV-1 vaccine remains the induction of protective antibodies. A rationale approach is to target antigen to specific receptors on dendritic cells (DC) via fused monoclonal antibodies (mAb).…
read more here.
Keywords:
specific humoral;
human langerin;
tfh cells;
targeting human ... See more keywords